Missouri HB 1031: Adds provisions relating to pharmaceutical cost transparency

Status: Referred: Health and Mental Health Policy(H) (as of 2019-05-17)

State: Missouri · Session: 2019 · Bill: HB 1031

Sponsors: Sain, Matt

View Missouri HB 1031 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.